echemi logo
Product
  • Product
  • Supplier
  • Inquiry
    Home > Active Ingredient News > Study of Nervous System > Hot research The latest research progress of Alzheimer's disease

    Hot research The latest research progress of Alzheimer's disease

    • Last Update: 2021-09-30
    • Source: Internet
    • Author: User
    Search more information of high quality chemicals, good prices and reliable suppliers, visit www.echemi.com
    "September is World Alzheimer's Disease Month-during this time it is a time to light up the courage for 50 million people with Alzheimer's disease and other dementias worldwide
    .

    Wiley is honored to publish three Alzheimer's Disease Association books .
    And will focus on the most shared Alzheimer’s and dementia research published in these journals in the past year
    .

    Original title: Failure to demonstrate efficacy of aducanumab: An analysis of the EMERGE and ENGAGE trials as reported by Biogen, December 2019 .
    onlinelibrary.
    wiley.
    com/doi/10.
    1002/alz.
    12213 Original title: COVID-19 and dementia: Analyses of risk, disparity, and outcomes from electronic health records in the US Alzheimer's AssociationFebruary 2021 link to the original text: https://alz-journals.
    onlinelibrary.
    wiley.
    com/doi/10.
    1002/alz.
    12296 Original title: 2021 Alzheimer's disease facts and figures from the journal: Alzheimer's & Dementia: the Journal of the Alzheimer's AssociationMarch 2021 original link: https://alz-journals.
    onlinelibrary.
    wiley.
    com/doi/10.
    1002/alz.
    12328 Original title: Estimating the global mortality from Alzheimer's disease and other dementias: A new method and results from the Global Burden of Disease study 2019 From the journal: Alzheimer's & Dementia: the Journal of the Alzheimer's Association December 2020 Original link: https:// doi.
    org/10.
    1002/alz.
    042236 Original title: A quadratic function of activation in individuals at risk of Alzheimer's disease from the journal: Alzheimer's & Dementia: Diagnosis, Assessment & Disease MonitoringJanuary 2021 Original link: https://doi.
    org/ 10.
    1002/dad2.
    12139 Original title: Association of the use of hearing aids with the conversion from mild cognitive impairment to dementia and progression of dementia: A longitudinal retrospective study From the journal: Alzheimer's & Dementia: Translational Research & Clinical Interventions February 2021 https://alz-journals.
    onlinelibrary.
    wiley.
    com/doi/10.
    1002/trc2.
    12122 Original title: Genetic Risk of Alzheimer's Disease and Sleep Duration in Non-Demented Elders from the journal: Annals of NeurologyJanuary 2021 Original link: https://onlinelibrary.
    wiley.
    com/doi/epdf/10.
    1002/ana.
    25910 Original title: Causal Associations Between Modifiable Risk Factors and the Alzheimer's Phenome from the journal: Annals of NeurologyJanuary 2021 Original link: https://onlinelibrary.
    wiley.
    com/doi/epdf/10.
    1002/ana.
    25918 Original title: Ante- and postmortem tau in autosomal Dominant and late-onset Alzheimer's disease comes from the journal: Annals of Clinical and Translational NeurologyDecember 2020 Original link: https://onlinelibrary.
    wiley.
    com/doi/10.
    1002/acn3.
    51237 Wiley’s Alzheimer’s disease research journal MoreWiley Promote world progress and development with scientific research and education25910 Original title: Causal Associations Between Modifiable Risk Factors and the Alzheimer's Phenome from the journal: Annals of NeurologyJanuary 2021 Original link: https://onlinelibrary.
    wiley.
    com/doi/epdf/10.
    1002/ana.
    25918 Original title: Ante- and postmortem tau in autosomal dominant and late-onset Alzheimer's disease from the journal: Annals of Clinical and Translational NeurologyDecember 2020 Original link: https://onlinelibrary.
    wiley.
    com/doi/10.
    1002/acn3.
    51237 About Alzheimer's disease published by Wiley Disease research journal MoreWiley promotes world progress and development with scientific research and education25910 Original title: Causal Associations Between Modifiable Risk Factors and the Alzheimer's Phenome from the journal: Annals of NeurologyJanuary 2021 Original link: https://onlinelibrary.
    wiley.
    com/doi/epdf/10.
    1002/ana.
    25918 Original title: Ante- and postmortem tau in autosomal dominant and late-onset Alzheimer's disease from the journal: Annals of Clinical and Translational NeurologyDecember 2020 Original link: https://onlinelibrary.
    wiley.
    com/doi/10.
    1002/acn3.
    51237 About Alzheimer's disease published by Wiley Disease research journal MoreWiley promotes world progress and development with scientific research and education
    .

    By providing publications, platforms, and services, we help students, researchers, universities, and companies achieve their goals in an ever-changing world
    .

    For more than 200 years, we have always brought continuous and stable performance to all stakeholders
    .

    The company's website is
    .

    Like, watch, share, let's have a one-click triple connection!
    This article is an English version of an article which is originally in the Chinese language on echemi.com and is provided for information purposes only. This website makes no representation or warranty of any kind, either expressed or implied, as to the accuracy, completeness ownership or reliability of the article or any translations thereof. If you have any concerns or complaints relating to the article, please send an email, providing a detailed description of the concern or complaint, to service@echemi.com. A staff member will contact you within 5 working days. Once verified, infringing content will be removed immediately.

    Contact Us

    The source of this page with content of products and services is from Internet, which doesn't represent ECHEMI's opinion. If you have any queries, please write to service@echemi.com. It will be replied within 5 days.

    Moreover, if you find any instances of plagiarism from the page, please send email to service@echemi.com with relevant evidence.